Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

8.12USD
16 Feb 2018
Change (% chg)

$-0.08 (-0.98%)
Prev Close
$8.20
Open
$8.17
Day's High
$8.22
Day's Low
$8.01
Volume
11,130
Avg. Vol
27,010
52-wk High
$22.01
52-wk Low
$7.64

Chart for

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: --
Market Cap(Mil.): $348.98
Shares Outstanding(Mil.): 20.93
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Corvus Pharmaceuticals reports third quarter 2017 financial results

* Corvus Pharmaceuticals reports third quarter 2017 financial results and clinical program update

02 Nov 2017

BRIEF-Corvus Pharmaceuticals entered into a sales agreement with Cowen and Co LLC‍​

* Corvus Pharmaceuticals - On September 20, 2017, Corvus Pharmaceuticals, Inc entered into a sales agreement with Cowen and Company, LLC‍​

20 Sep 2017

Earnings vs. Estimates